19 June 2013
Keywords: cats, shareholders, ok, astrazeneca, subscription, uk, cambridge
Article | 10 January 2005
The UK's Cambridge Antibody Technology, a company engaged in drug discovery through the use of human monoclonal antibodies, says that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2005
18 June 2013
© 2013 thepharmaletter.com